The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

R. Kang, D. Tang, N. E. Schapiro, K. M. Livesey, A. Farkas, P. Loughran, A. Bierhaus, M. T. Lotze, H. J. Zeh

Research output: Contribution to journalArticle

190 Citations (Scopus)

Abstract

Activation of the induced receptor for advanced glycation end products (RAGE) leads to initiation of NF-B and MAP kinase signaling pathways, resulting in propagation and perpetuation of inflammation. RAGE-knockout animals are less susceptible to acute inflammation and carcinogen-induced tumor development. We have reported that most forms of tumor cell death result in release of the RAGE ligand, high-mobility group protein 1 (HMGB1). We now report a novel role for RAGE in the tumor cell response to stress. Targeted knockdown of RAGE in the tumor cell, leads to increased apoptosis, diminished autophagy and decreased tumor cell survival. In contrast, overexpression of RAGE is associated with enhanced autophagy, diminished apoptosis and greater tumor cell viability. RAGE limits apoptosis through a p53-dependent mitochondrial pathway. Moreover, RAGE-sustained autophagy is associated with decreased phosphorylation of mammalian target of rapamycin (mTOR) and increased Beclin-1/VPS34 autophagosome formation. These findings show that the inflammatory receptor, RAGE, has a heretofore unrecognized role in the tumor cell response to stress. Furthermore, these studies establish a direct link between inflammatory mediators in the tumor microenvironment and resistance to programmed cell death. Our data suggest that targeted inhibition of RAGE or its ligands may serve as novel targets to enhance current cancer therapies.

Original languageEnglish (US)
Pages (from-to)666-676
Number of pages11
JournalCell Death and Differentiation
Volume17
Issue number4
DOIs
StatePublished - Apr 1 2010
Externally publishedYes

Fingerprint

Autophagy
Cell Survival
Apoptosis
Neoplasms
Cell Death
Advanced Glycosylation End Product-Specific Receptor
High Mobility Group Proteins
HMGB1 Protein
Ligands
Inflammation
Tumor Microenvironment
MAP Kinase Signaling System
Sirolimus
Carcinogens
Phosphorylation

Keywords

  • Apoptosis
  • Autophagy
  • Chemotherapy
  • HMGB1
  • RAGE

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. / Kang, R.; Tang, D.; Schapiro, N. E.; Livesey, K. M.; Farkas, A.; Loughran, P.; Bierhaus, A.; Lotze, M. T.; Zeh, H. J.

In: Cell Death and Differentiation, Vol. 17, No. 4, 01.04.2010, p. 666-676.

Research output: Contribution to journalArticle

Kang, R. ; Tang, D. ; Schapiro, N. E. ; Livesey, K. M. ; Farkas, A. ; Loughran, P. ; Bierhaus, A. ; Lotze, M. T. ; Zeh, H. J. / The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. In: Cell Death and Differentiation. 2010 ; Vol. 17, No. 4. pp. 666-676.
@article{da5f2d2fce3a49c6bc43e12d8d0a3ee6,
title = "The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival",
abstract = "Activation of the induced receptor for advanced glycation end products (RAGE) leads to initiation of NF-B and MAP kinase signaling pathways, resulting in propagation and perpetuation of inflammation. RAGE-knockout animals are less susceptible to acute inflammation and carcinogen-induced tumor development. We have reported that most forms of tumor cell death result in release of the RAGE ligand, high-mobility group protein 1 (HMGB1). We now report a novel role for RAGE in the tumor cell response to stress. Targeted knockdown of RAGE in the tumor cell, leads to increased apoptosis, diminished autophagy and decreased tumor cell survival. In contrast, overexpression of RAGE is associated with enhanced autophagy, diminished apoptosis and greater tumor cell viability. RAGE limits apoptosis through a p53-dependent mitochondrial pathway. Moreover, RAGE-sustained autophagy is associated with decreased phosphorylation of mammalian target of rapamycin (mTOR) and increased Beclin-1/VPS34 autophagosome formation. These findings show that the inflammatory receptor, RAGE, has a heretofore unrecognized role in the tumor cell response to stress. Furthermore, these studies establish a direct link between inflammatory mediators in the tumor microenvironment and resistance to programmed cell death. Our data suggest that targeted inhibition of RAGE or its ligands may serve as novel targets to enhance current cancer therapies.",
keywords = "Apoptosis, Autophagy, Chemotherapy, HMGB1, RAGE",
author = "R. Kang and D. Tang and Schapiro, {N. E.} and Livesey, {K. M.} and A. Farkas and P. Loughran and A. Bierhaus and Lotze, {M. T.} and Zeh, {H. J.}",
year = "2010",
month = "4",
day = "1",
doi = "10.1038/cdd.2009.149",
language = "English (US)",
volume = "17",
pages = "666--676",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

AU - Kang, R.

AU - Tang, D.

AU - Schapiro, N. E.

AU - Livesey, K. M.

AU - Farkas, A.

AU - Loughran, P.

AU - Bierhaus, A.

AU - Lotze, M. T.

AU - Zeh, H. J.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Activation of the induced receptor for advanced glycation end products (RAGE) leads to initiation of NF-B and MAP kinase signaling pathways, resulting in propagation and perpetuation of inflammation. RAGE-knockout animals are less susceptible to acute inflammation and carcinogen-induced tumor development. We have reported that most forms of tumor cell death result in release of the RAGE ligand, high-mobility group protein 1 (HMGB1). We now report a novel role for RAGE in the tumor cell response to stress. Targeted knockdown of RAGE in the tumor cell, leads to increased apoptosis, diminished autophagy and decreased tumor cell survival. In contrast, overexpression of RAGE is associated with enhanced autophagy, diminished apoptosis and greater tumor cell viability. RAGE limits apoptosis through a p53-dependent mitochondrial pathway. Moreover, RAGE-sustained autophagy is associated with decreased phosphorylation of mammalian target of rapamycin (mTOR) and increased Beclin-1/VPS34 autophagosome formation. These findings show that the inflammatory receptor, RAGE, has a heretofore unrecognized role in the tumor cell response to stress. Furthermore, these studies establish a direct link between inflammatory mediators in the tumor microenvironment and resistance to programmed cell death. Our data suggest that targeted inhibition of RAGE or its ligands may serve as novel targets to enhance current cancer therapies.

AB - Activation of the induced receptor for advanced glycation end products (RAGE) leads to initiation of NF-B and MAP kinase signaling pathways, resulting in propagation and perpetuation of inflammation. RAGE-knockout animals are less susceptible to acute inflammation and carcinogen-induced tumor development. We have reported that most forms of tumor cell death result in release of the RAGE ligand, high-mobility group protein 1 (HMGB1). We now report a novel role for RAGE in the tumor cell response to stress. Targeted knockdown of RAGE in the tumor cell, leads to increased apoptosis, diminished autophagy and decreased tumor cell survival. In contrast, overexpression of RAGE is associated with enhanced autophagy, diminished apoptosis and greater tumor cell viability. RAGE limits apoptosis through a p53-dependent mitochondrial pathway. Moreover, RAGE-sustained autophagy is associated with decreased phosphorylation of mammalian target of rapamycin (mTOR) and increased Beclin-1/VPS34 autophagosome formation. These findings show that the inflammatory receptor, RAGE, has a heretofore unrecognized role in the tumor cell response to stress. Furthermore, these studies establish a direct link between inflammatory mediators in the tumor microenvironment and resistance to programmed cell death. Our data suggest that targeted inhibition of RAGE or its ligands may serve as novel targets to enhance current cancer therapies.

KW - Apoptosis

KW - Autophagy

KW - Chemotherapy

KW - HMGB1

KW - RAGE

UR - http://www.scopus.com/inward/record.url?scp=77949542302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949542302&partnerID=8YFLogxK

U2 - 10.1038/cdd.2009.149

DO - 10.1038/cdd.2009.149

M3 - Article

C2 - 19834494

AN - SCOPUS:77949542302

VL - 17

SP - 666

EP - 676

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 4

ER -